MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0038148
Eart Pharmaceuticals Private Limited
Eart Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.46 Lakh
▼ 55% YoY
Net loss · FY 2025
₹7.95 Lakh
Net margin -69.4%
EBITDA · FY 2025
-₹7.76 Lakh
EBITDA margin -67.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Eart Pharmaceuticals Private Limited
Data last updated:
Eart Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC378972. Its GSTIN is 07AAGCE3969F1ZG (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Nandan and Premjeet Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 995 – A – 23 G/F W.No – 7 Mehrauli Near Sabji Mandi, Delhi, India – 110030.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.46 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹7.95 Lakh (net margin -69.4%) and EBITDA of -₹7.76 Lakh (EBITDA margin -67.7%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years.
Eart Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0038148).
Company details
CIN U24290DL2021PTC378972
Registration Number 378972
Incorporation Date 22 March 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0038148
Key People
Raj Nandan Director Premjeet Kumar Singh Director Recognitions & Rankings of Eart Pharmaceuticals
Contact details
Eart Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address995 – A – 23 G/F W.No – 7 Mehrauli Near Sabji Mandi, Delhi, India – 110030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eart Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Eart Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Eart Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eart Pharmaceuticals Private Limited, buy the company report.
Financials of Eart Pharmaceuticals Private Limited
FY 2025 filings availableEart Pharmaceuticals Private Limited reported revenue of ₹11.46 Lakh (down 55% YoY) for FY 2025.
Revenue · FY 2025
₹11.46 Lakh ▼ 55%
Net loss · FY 2025
₹7.95 Lakh margin -69.4%
EBITDA · FY 2025
-₹7.76 Lakh margin -67.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 55%
3 years · compounded
▲ 68%
EBITDA CAGR growth
3 years · compounded
▼ 438%
Revenue fell 55% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 68%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -67.7% | ||||
| Net Profit Margin | -69.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eart Pharmaceuticals Private Limited, buy the company report.
Board of directors of Eart Pharmaceuticals Private Limited
Eart Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Nandan | Director | 22 Mar 2021 | 5 Years 7 Months | Current |
| Premjeet Kumar Singh Also directs: Maa Vindhyawashini Stone Crusher LLP | Director | 22 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
Eart Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healthsys Pharmaceuticals Private Limited | ₹11.54 Lakh (FY 2023) | 31.0% | Pune, Maharashtra, India | |||
| Manfred Pharmaceuticals Private Limited | ₹11.51 Lakh (FY 2025) | 24.0% | Kolhapur, Maharashtra, India | |||
| Country First Pharmaceuticals Private Limited | ₹11.49 Lakh (FY 2024) | 11978.0% | Agra, Uttar Pradesh, India | |||
| Eart Pharmaceuticals Private Limitedthis company | ₹11.46 Lakh (FY 2025) | -₹7.95 Lakh | -69.4% | -55.0% | Delhi, India | |
| Sunlight Pharmaceuticals Private Limited | ₹11.45 Lakh (FY 2025) | -2.0% | Gorakhpur, Uttar Pradesh, India | |||
| Curador Pharmaceuticals Private Limited | ₹11.45 Lakh (FY 2025) | -35.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Eart Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eart Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eart Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eart Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Eart Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCE3969F1ZG | Delhi | Active | 01 Aug 2021 |
| 20AAGCE3969F1ZS | Jharkhand | Active | 04 Oct 2021 |
To see the full GST registrations and return filing status of Eart Pharmaceuticals Private Limited, buy the company report.
Recent activity
Eart Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Priyankan Raj ceased to be Director on 17 Aug 2022.
AGM
Eart Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Eart Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Priyankan Raj ceased to be Director.
Appointed
Premjeet Kumar Singh was appointed as Director.
Appointed
Raj Nandan was appointed as Director.
Incorporation
22 Mar 2021
Eart Pharmaceuticals Private Limited was registered on 22 Mar 2021 with Roc Delhi I & aged 5 years 7 months as per MCA records.
Frequently asked questions
Eart Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 2021 (5+ years old) and is registered under CIN U24290DL2021PTC378972.
Eart Pharmaceuticals has 2 current directors:
- Raj Nandan - Director
- Premjeet Kumar Singh - Director
The latest financial statements of Eart Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Eart Pharmaceuticals is 07AAGCE3969F1ZG, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 20AAGCE3969F1ZS (Jharkhand).
The CIN (Corporate Identification Number) of Eart Pharmaceuticals is U24290DL2021PTC378972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eart Pharmaceuticals was incorporated on 22 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Eart Pharmaceuticals by revenue are Healthsys Pharmaceuticals Private Limited, Manfred Pharmaceuticals Private Limited, Country First Pharmaceuticals Private Limited, Sunlight Pharmaceuticals Private Limited, Curador Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Priyankan Raj ceased to be Director on 17 Aug 2022. Premjeet Kumar Singh was appointed as Director on 22 Mar 2021. Raj Nandan was appointed as Director on 22 Mar 2021.
Yes, Eart Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0038148).
The registered office of Eart Pharmaceuticals is at 995 – A – 23 GF W.No – 7 Mehrauli Near Sabji Mandi, Delhi, India – 110030.
Eart Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages